5-HTP için Uykuya Dalma Güçlüğü
D Araştırma Yalnızca ön araştırmalar mevcuttur (laboratuvar çalışmaları, olgu raporları).7 çalışmaya dayanmaktadır. 7/7 çalışma olumlu etkiler göstermektedir.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'sleepcited.com';
const params = 'ingredient\u003D5\u002Dhtp\u0026condition\u003Dsleep\u002Donset\u002Dlatency';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
D
Sonuç
There is not yet enough human research to confirm that 5-HTP helps you fall asleep faster, though early animal research is encouraging.
- All 7 studies are animal or preclinical studies with no human trial data
- Evidence grade is D, indicating very limited evidence
- 5-HTP works through the serotonin system, which plays a role in sleep onset
- Human clinical trials are needed before recommendations can be made
Key Study Findings
Animal study
Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 …
Dose: None
vs: Placebo
Etki: None
None
Animal Study
Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats.
Dose: Cinnamic acid (CA) administered to rats (dose not specified)
vs: Placebo
Etki: None
None
animal study (preclinical)
Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides.
Dose: up to 96 mg/kg
vs: Placebo
Etki: None
None
animal study (preclinical)
Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems.
Dose: not fully specified (dose ranges tested in Drosophila, ICR mice, and SD rats)
vs: Placebo
Etki: None
p < 0.001 (combined GABA/5-HTP
animal study (preclinical)
Flos Albiziae aqueous extract and its active constituent quercetin potentiate the hypnotic effect of pentobarbital …
Dose: various doses; pentobarbital 50 mg/kg (full dose) or 28 mg/kg (sub-hypnotic dose) IP
vs: Placebo
Etki: None
None
In Vitro
Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep …
Dose: 5-45 mg/kg i.p. schizandrin
vs: Placebo
Etki: Dose-dependent decrease in sleep latency and increase in sleep duration
None
Key Statistics
7
Çalışmalar
--
Katılımcılar
↑
Positive
D
Derece
Referenced Papers
Psychopharmacology
2025
5 atıf
International immunopharmacology
2025
1 atıf
Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides.
Other
RSC advances
2019
13 atıf
Nutrition research and …
2018
12 atıf
Biomedical reports
2015
12 atıf
European journal of …
2014
43 atıf
Pharmacology, biochemistry, and …
2008
76 atıf
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Yaygın Kullanılan Dozajlar
- sleep:
- 100-300 mg, 30-45 min before bed
Üst sınır: Not established; serotonin syndrome risk with SSRIs
Araştırmalarda İncelenen Dozajlar
| Dozaj | Süre | Etki | N |
|---|---|---|---|
| None | -- | Positive | -- |
| Cinnamic acid (CA) administered to rats (dose not specified) | -- | Positive | -- |
| up to 96 mg/kg | -- | Positive | -- |
| not fully specified (dose ranges tested in Drosophila, ICR mice, and SD rats) | -- | Positive | -- |
| various doses; pentobarbital 50 mg/kg (full dose) or 28 mg/kg (sub-hypnotic dose) IP | -- | Positive | -- |
| 5-45 mg/kg i.p. schizandrin | -- | Positive | -- |
| Spinosin various doses; pentobarbital 45 mg/kg or 28 mg/kg i.p.; 5-HTP 2.5 mg/kg i.p.; PCPA 300 mg/k | -- | Positive | -- |
En iyi alım zamanı: 30-45 minutes before bed
Safety & Side Effects
Bildirilen Yan Etkiler
- ⚠ Nausea
- ⚠ Diarrhea
- ⚠ Heartburn
- ⚠ Stomach pain
- ⚠ Drowsiness
Bilinen Etkileşimler
- ● SSRIs/SNRIs — serious risk of serotonin syndrome
- ● MAOIs — dangerous serotonin accumulation
- ● Tramadol — increased serotonin syndrome risk
- ● Carbidopa — may cause scleroderma-like skin changes
Tolere edilebilir üst alım: Not established; serotonin syndrome risk with SSRIs
Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.
Frequently Asked Questions
Does 5-HTP help with Uykuya Dalma Güçlüğü?
Based on 7 studies with 0 participants, there is preliminary evidence that needs more research that 5-HTP may support Uykuya Dalma Güçlüğü management. Our evidence grade is D (Very Early Research).
How much 5-HTP should I take for Uykuya Dalma Güçlüğü?
Studies have used various dosages. A commonly studied range is 100-300 mg, 30-45 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 5-HTP?
Reported side effects may include Nausea, Diarrhea, Heartburn, Stomach pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 5-HTP and Uykuya Dalma Güçlüğü?
We rate the evidence as Grade D (Very Early Research). This rating is based on 7 peer-reviewed studies with 0 total participants. The overall direction of effect is positive.
Related Evidence
Şu durum için diğer içerikler: Uykuya Dalma Güçlüğü
5-HTP diğer sağlık durumları için
References
- [1] Jingyi Li et al.. Psychopharmacology (Berl). 2025. Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice. doi:10.1007/s00213-025-06828-5 PubMed
- [2] Xiaona Ye et al.. Int Immunopharmacol. 2025. Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats. doi:10.1016/j.intimp.2025.114852 PubMed
- [3] Ning Mou et al.. RSC Adv. 2019. Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides. doi:10.1039/c9ra01549c PubMed
- [4] Ki-Bae Hong et al.. Nutr Res Pract. 2018. Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems. doi:10.4162/nrp.2018.12.3.208 PubMed
- [5] Meng-Fei Ye et al.. Biomed Rep. 2015. Flos Albiziae aqueous extract and its active constituent quercetin potentiate the hypnotic effect of pentobarbital via the serotonergic system. doi:10.3892/br.2015.518 PubMed
- [6] Chenning Zhang et al.. Eur J Pharmacol. 2014. Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep behaviors in mice. doi:10.1016/j.ejphar.2014.09.012 PubMed
- [7] Li-En Wang et al.. Pharmacol Biochem Behav. 2008. Spinosin, a C-glycoside flavonoid from semen Zizhiphi Spinozae, potentiated pentobarbital-induced sleep via the serotonergic system. doi:10.1016/j.pbb.2008.03.022 PubMed
FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.